167 related articles for article (PubMed ID: 25002871)
1. Efficacy of Hydrochlorothiazide and low renal solute feed in Neonatal Central Diabetes Insipidus with transition to Oral Desmopressin in early infancy.
Abraham MB; Rao S; Price G; Choong CS
Int J Pediatr Endocrinol; 2014; 2014(1):11. PubMed ID: 25002871
[TBL] [Abstract][Full Text] [Related]
2. Use of Chlorothiazide in the Management of Central Diabetes Insipidus in Early Infancy.
Raisingani M; Palliyil Gopi R; Shah B
Case Rep Pediatr; 2017; 2017():2407028. PubMed ID: 28553553
[TBL] [Abstract][Full Text] [Related]
3. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics.
Rivkees SA; Dunbar N; Wilson TA
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):459-69. PubMed ID: 17550208
[TBL] [Abstract][Full Text] [Related]
4. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study.
Kristof RA; Rother M; Neuloh G; Klingmüller D
J Neurosurg; 2009 Sep; 111(3):555-62. PubMed ID: 19199508
[TBL] [Abstract][Full Text] [Related]
5. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
6. Intranasal desmopressin-induced hyponatremia.
Williford SL; Bernstein SA
Pharmacotherapy; 1996; 16(1):66-74. PubMed ID: 8700794
[TBL] [Abstract][Full Text] [Related]
7. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
Spatenkova V; Bradac O; Skrabalek P
J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
[TBL] [Abstract][Full Text] [Related]
8. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
9. Thiazide Diuretics in the Management of Young Children with Central Diabetes Insipidus.
Al Nofal A; Lteif A
J Pediatr; 2015 Sep; 167(3):658-61. PubMed ID: 26130110
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
[TBL] [Abstract][Full Text] [Related]
11. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
12. Hydrochlorothiazide in intensive care unit-acquired hypernatremia: A randomized controlled trial.
van IJzendoorn MM; Buter H; Kingma WP; Koopmans M; Navis G; Boerma EC
J Crit Care; 2017 Apr; 38():225-230. PubMed ID: 27984823
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine-induced hyponatremia in a patient with partial central diabetes insipidus.
Kamiyama T; Iseki K; Kawazoe N; Takishita S; Fukiyama K
Nephron; 1993; 64(1):142-5. PubMed ID: 8502320
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus.
Korkmaz HA; Coşkunol F; Barışık V; Ozkan B
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):925-929. PubMed ID: 37658767
[TBL] [Abstract][Full Text] [Related]
15. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin administration in children with central diabetes insipidus: a retrospective review.
Ooi HL; Maguire AM; Ambler GR
J Pediatr Endocrinol Metab; 2013; 26(11-12):1047-52. PubMed ID: 23843580
[TBL] [Abstract][Full Text] [Related]
17. Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management.
Mutter CM; Smith T; Menze O; Zakharia M; Nguyen H
Cureus; 2021 Feb; 13(2):e13523. PubMed ID: 33786230
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus.
Pedersen AN; Andreassen M; Rasmussen AK; Krogh J
Horm Metab Res; 2024 Mar; 56(3):206-213. PubMed ID: 37879354
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors?
Thumfart J; Roehr CC; Kapelari K; Querfeld U; Eggert P; Müller D
J Urol; 2005 Jul; 174(1):294-8; discussion 298. PubMed ID: 15947670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
